On Tuesday, ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)’s shares inclined 5.07% to $12.64.
ZIOPHARM Oncology, Inc. (ZIOP) a biotechnology company, employs gene expression, control, and cell technologies to deliver cell-based therapies for the treatment of cancer. Its synthetic immuno-oncology programs, in partnership with Intrexon Corporation and the MD Anderson Cancer Center, comprise chimeric antigen receptor T cell (CAR-T) and other adoptive cell based approaches that use both non-viral and viral gene transfer methods for broad scalability.
ZIOPHARM Oncology, Inc., a biotechnology company, employs gene expression, control, and cell technologies to deliver cell-based therapies for the treatment of cancer. Its synthetic immuno-oncology programs, in partnership with Intrexon Corporation and the MD Anderson Cancer Center, comprise chimeric antigen receptor T cell (CAR-T) and other adoptive cell based approaches that use both non-viral and viral gene transfer methods for broad scalability.
Dynegy Inc. (NYSE:DYN)’s shares gained 3.10% to $24.95.
Dynegy Inc. (DYN) declared that its Board of Directors declared a dividend of $1.34375 per share on the outstanding 5.375% Series A Mandatory Convertible Preferred Stock that will be paid on August 3, 2015 to stockholders of record of the Mandatory Convertible Preferred Stock on July 15, 2015. The dividend is for the dividend period starting on May 1, 2015 and ending on July 31, 2015.
Dynegy Inc., through its auxiliaries, produces and sells electric energy, capacity, and ancillary services in the United States. It operates in three segments, Coal, IPH, and Gas. The company sells its services on a wholesale basis from its power generation facilities. It has a fleet of 15 power plants in 5 states totaling about 13,000 megawatts of generating capacity.
At the end of Tuesday’s trade, Lear Corporation (NYSE:LEA)‘s shares surged 2.52% to $102.19.
Lear Corporation (LEA), a leading global supplier of automotive seating and electrical distribution systems, recently stated financial results for the second quarter. Highlights comprise:
- Sales of $4.6 billion, up 1% from a year ago; 10% growth not taking into account impact of foreign exchange.
- Record core operating earnings of $337 million, up 23%.
- Adjusted earnings per share of $2.82, up 33%.
- Core operating margin of 7.3%, up from 6.0% a year ago.
- Improved margins in both business segments.
- Returned $142 million to shareholders through share repurchases and dividends.
- Increasing full year outlook for earnings and free cash flow.
Lear Corporation designs, develops, engineers, manufactures, assembles, and supplies automotive seating, electrical distribution systems, and related components primarily to automotive original equipment manufacturers worldwide. It operates through two segments, Seating and Electrical.
Williams Partners LP (NYSE:WPZ), ended its Tuesdays trading session with 3.35% gain, and closed at $47.16.
Williams Partners L.P. (WPZ) declared a regular quarterly cash distribution of $0.85 per unit for its common unitholders.
The board of directors of the partnership’s general partner has approved the quarterly cash distribution, which is payable on Aug. 13, 2015, to common unitholders of record at the close of business on Aug. 6.
Williams Partners L.P., an energy infrastructure company, focuses on connecting North Americas hydrocarbon resource plays to growing markets for natural gas and natural gas liquids (NGL). It operates in Northeast G&P, Atlantic-Gulf, West, and NGL & Petchem Services segments.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
